AAAAAA

   
Results: 1-25 | 26-50 | 51-60
Results: 1-25/60
INFUSION OF DONOR PERIPHERAL-BLOOD MONONUCLEAR-CELLS TO TREAT RELAPSEAFTER TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
Authors: PORTER DL ANTIN JH
Citation: Dl. Porter et Jh. Antin, INFUSION OF DONOR PERIPHERAL-BLOOD MONONUCLEAR-CELLS TO TREAT RELAPSEAFTER TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA, Hematology/oncology clinics of North America, 12(1), 1998, pp. 123
INITIAL THERAPY FOR CHRONIC MYELOGENOUS LEUKEMIA - PLAYING THE ODDS
Authors: LEE SJ ANASETTI C HOROWITZ MM ANTIN JH
Citation: Sj. Lee et al., INITIAL THERAPY FOR CHRONIC MYELOGENOUS LEUKEMIA - PLAYING THE ODDS, Journal of clinical oncology, 16(9), 1998, pp. 2897-2903
COMPARISON OF MULTIPLE IMMUNIZATION SCHEDULES FOR HAEMOPHILUS-INFLUENZAE TYPE-B CONJUGATE AND TETANUS TOXOID VACCINES FOLLOWING BONE-MARROWTRANSPLANTATION
Authors: VANCE E GEORGE S GUINAN EC WHEELER C ANTIN JH AMBROSINO DM MOLRINE DC
Citation: E. Vance et al., COMPARISON OF MULTIPLE IMMUNIZATION SCHEDULES FOR HAEMOPHILUS-INFLUENZAE TYPE-B CONJUGATE AND TETANUS TOXOID VACCINES FOLLOWING BONE-MARROWTRANSPLANTATION, Bone marrow transplantation, 22(8), 1998, pp. 735-741
PHARMACOKINETICS AND BIODISTRIBUTION OF IN-111-DTPA-G-CSF IN NONHUMAN-PRIMATES
Authors: CONNORS JM KRONAUGE JF CASTRONOVO F MANNTING F JONES AG SIEFF C ANTIN JH
Citation: Jm. Connors et al., PHARMACOKINETICS AND BIODISTRIBUTION OF IN-111-DTPA-G-CSF IN NONHUMAN-PRIMATES, The Journal of nuclear medicine, 39(5), 1998, pp. 843-843
ABO INCOMPATIBILITY AS A PROGNOSTIC FACTOR IN ALLOGENEIC STEM-CELL TRANSPLANTATION
Authors: BENJAMIN RJ MCGURK S RAISTON M CHURCHILL WH ANTIN JH
Citation: Rj. Benjamin et al., ABO INCOMPATIBILITY AS A PROGNOSTIC FACTOR IN ALLOGENEIC STEM-CELL TRANSPLANTATION, Transfusion, 38(10), 1998, pp. 258-258
A COMPARISON OF RELATED AND UNRELATED MARROW DONORS
Authors: CHANG G MCGARIGLE C SPITZER TR MCAFEE SL HARRIS F PIERCY K GOETZ MA ANTIN JH
Citation: G. Chang et al., A COMPARISON OF RELATED AND UNRELATED MARROW DONORS, Psychosomatic medicine, 60(2), 1998, pp. 163-167
PHASE-III STUDY COMPARING METHOTREXATE AND TACROLIMUS (PROGRAF, FK506) WITH METHOTREXATE AND CYCLOSPORINE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS AFTER HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION
Authors: RATANATHARATHORN V NASH RA PRZEPIORKA D DEVINE SM KLEIN JL WEISDORF D FAY JW NADEMANEE A ANTIN JH CHRISTIANSEN NP VANDERJAGT R HERZIG RH LITZOW MR WOLFF SN LONGO WL PETERSEN FB KARANES C AVALOS B STORB R BUELL DN MAHER RM FITZSIMMONS WE WINGARD JR
Citation: V. Ratanatharathorn et al., PHASE-III STUDY COMPARING METHOTREXATE AND TACROLIMUS (PROGRAF, FK506) WITH METHOTREXATE AND CYCLOSPORINE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS AFTER HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION, Blood, 92(7), 1998, pp. 2303-2314
TREATMENT OF SEVERE VENOOCCLUSIVE DISEASE WITH DEFIBROTIDE - COMPASSIONATE USE RESULTS IN RESPONSE WITHOUT SIGNIFICANT TOXICITY IN A HIGH-RISK POPULATION
Authors: RICHARDSON PG ELIAS AD KRISHNAN A WHEELER C NATH R HOPPENSTEADT D KINCHLA NM NEUBERG D WALLER EK ANTIN JH SOIFFER R VREDENBURGH J LILL M WOOLFREY AE BEARMAN SI IACOBELLI M FAREED J GUINAN EC
Citation: Pg. Richardson et al., TREATMENT OF SEVERE VENOOCCLUSIVE DISEASE WITH DEFIBROTIDE - COMPASSIONATE USE RESULTS IN RESPONSE WITHOUT SIGNIFICANT TOXICITY IN A HIGH-RISK POPULATION, Blood, 92(3), 1998, pp. 737-744
THE COSTS AND COST-EFFECTIVENESS OF UNRELATED DONOR BONE-MARROW TRANSPLANTATION FOR CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA
Authors: LEE SJ ANASETTI C KUNTZ KM PATTEN J ANTIN JH WEEKS JC
Citation: Sj. Lee et al., THE COSTS AND COST-EFFECTIVENESS OF UNRELATED DONOR BONE-MARROW TRANSPLANTATION FOR CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA, Blood, 92(11), 1998, pp. 4047-4052
A PHASE-II STUDY OF BTI-322, A MONOCLONAL ANTI-CD2 ANTIBODY, FOR TREATMENT OF STEROID-RESISTANT ACUTE GRAFT-VERSUS-HOST DISEASE
Authors: PRZEPIORKA D PHILLIPS GL RATANATHARATHORN V COTTLERFOX M SEHN LH ANTIN JH LEBHERZ D AWWAD M HOPE J MCCLAIN JB
Citation: D. Przepiorka et al., A PHASE-II STUDY OF BTI-322, A MONOCLONAL ANTI-CD2 ANTIBODY, FOR TREATMENT OF STEROID-RESISTANT ACUTE GRAFT-VERSUS-HOST DISEASE, Blood, 92(11), 1998, pp. 4066-4071
PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF THE MEDIASTINUM - OUTCOME FOLLOWING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC-CELL TRANSPLANTATION
Authors: SEHN LH ANTIN JH SHULMAN LN MAUCH P ELIAS A KADIN ME WHEELER C
Citation: Lh. Sehn et al., PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF THE MEDIASTINUM - OUTCOME FOLLOWING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC-CELL TRANSPLANTATION, Blood, 91(2), 1998, pp. 717-723
EFFECTS OF GLUTAMINE SUPPLEMENTATION ON CIRCULATING LYMPHOCYTES AFTERBONE-MARROW TRANSPLANTATION - A PILOT-STUDY
Authors: ZIEGLER TR BYE RL PERSINGER RL YOUNG LS ANTIN JH WILMORE DW
Citation: Tr. Ziegler et al., EFFECTS OF GLUTAMINE SUPPLEMENTATION ON CIRCULATING LYMPHOCYTES AFTERBONE-MARROW TRANSPLANTATION - A PILOT-STUDY, The American journal of the medical sciences, 315(1), 1998, pp. 4-10
DONOR LEUKOCYTE INFUSIONS IN 140 PATIENTS WITH RELAPSED MALIGNANCY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: COLLINS RH SHPILBERG O DROBYSKI WR PORTER DL GIRALT S CHAMPLIN R GOODMAN SA WOLFF SN HU W VERFAILLIE C LIST A DALTON W OGNOSKIE N CHETRIT A ANTIN JH NEMUNAITIS J
Citation: Rh. Collins et al., DONOR LEUKOCYTE INFUSIONS IN 140 PATIENTS WITH RELAPSED MALIGNANCY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Journal of clinical oncology, 15(2), 1997, pp. 433-444
BONE-MARROW TRANSPLANTATION FOR THERAPY-RELATED MYELODYSPLASIA - COMPARISON WITH PRIMARY MYELODYSPLASIA
Authors: BALLEN KK GILLILAND DG GUINAN EC HSIEH CC PARSONS SK RIMM IJ FERRARA JLM BIERER BE WEINSTEIN HJ ANTIN JH
Citation: Kk. Ballen et al., BONE-MARROW TRANSPLANTATION FOR THERAPY-RELATED MYELODYSPLASIA - COMPARISON WITH PRIMARY MYELODYSPLASIA, Bone marrow transplantation, 20(9), 1997, pp. 737-743
ENERGY-LEVEL AND SLEEP QUALITY FOLLOWING BONE-MARROW TRANSPLANTATION
Authors: ANDRYKOWSKI MA CARPENTER JS GREINER CB ALTMAIER EM BURISH TG ANTIN JH GINGRICH R CORDOVA MJ HENSLEEDOWNEY PJ
Citation: Ma. Andrykowski et al., ENERGY-LEVEL AND SLEEP QUALITY FOLLOWING BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 20(8), 1997, pp. 669-679
ANTIBODY-RESPONSES TO TETANUS TOXOID AND HAEMOPHILUS-INFLUENZAE TYPE-B CONJUGATE VACCINES FOLLOWING AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSCT)
Authors: CHAN CY MOLRINE DC ANTIN JH WHEELER C GUINAN EC WEINSTEIN HJ PHILLIPS NR MCGARIGLE C HARVEY S SCHNIPPER C AMBROSINO DM
Citation: Cy. Chan et al., ANTIBODY-RESPONSES TO TETANUS TOXOID AND HAEMOPHILUS-INFLUENZAE TYPE-B CONJUGATE VACCINES FOLLOWING AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSCT), Bone marrow transplantation, 20(1), 1997, pp. 33-38
IDIOPATHIC THROMBOCYTOPENIC PURPURA FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION - TREATMENT WITH ANTI-D IMMUNOGLOBULIN
Authors: LEE SJ CHURCHILL WH KONUGRES A GILLILAND DG ANTIN JH
Citation: Sj. Lee et al., IDIOPATHIC THROMBOCYTOPENIC PURPURA FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION - TREATMENT WITH ANTI-D IMMUNOGLOBULIN, Bone marrow transplantation, 19(2), 1997, pp. 173-174
SUBSTANCE-ABUSE AND BONE-MARROW TRANSPLANT
Authors: CHANG G ANTIN JH ORAV EJ RANDALL U MCGARIGLE C BEHR HM
Citation: G. Chang et al., SUBSTANCE-ABUSE AND BONE-MARROW TRANSPLANT, The American journal of drug and alcohol abuse, 23(2), 1997, pp. 301-308
LIQUID-NITROGEN FREEZERS - A POTENTIAL SOURCE OF MICROBIAL-CONTAMINATION OF HEMATOPOIETIC STEM-CELL COMPONENTS
Authors: FOUNTAIN D RALSTON M HIGGINS N GORLIN JB UHL L WHEELER C ANTIN JH CHURCHILL WH BENJAMIN RJ
Citation: D. Fountain et al., LIQUID-NITROGEN FREEZERS - A POTENTIAL SOURCE OF MICROBIAL-CONTAMINATION OF HEMATOPOIETIC STEM-CELL COMPONENTS, Transfusion, 37(6), 1997, pp. 585-591
PREAPHERESIS PERIPHERAL-BLOOD CD34-CELL YIELD( MONONUCLEAR CELL COUNTS AS PREDICTORS OF PROGENITOR)
Authors: BENJAMIN RJ LINSLEY L FOUNTAIN D CHURCHILL WH SIEFF C CANNON ME UHL L GAYNES L ANTIN JH WHEELER C
Citation: Rj. Benjamin et al., PREAPHERESIS PERIPHERAL-BLOOD CD34-CELL YIELD( MONONUCLEAR CELL COUNTS AS PREDICTORS OF PROGENITOR), Transfusion, 37(1), 1997, pp. 79-85
GUILLAIN-BARRE-SYNDROME FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: WEN PY ALYEA EP SIMON D HERBST RS SOIFFER RJ ANTIN JH
Citation: Py. Wen et al., GUILLAIN-BARRE-SYNDROME FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Neurology, 49(6), 1997, pp. 1711-1714
PHARMACOKINETICS AND BIODISTRIBUTION OF IN-111-DTPA-G-CSF NONHUMAN-PRIMATES
Authors: CONNORS JM KRONAUGE J CASTRONOVO F MANNTING F JONES A SIEFF C ANTIN JH
Citation: Jm. Connors et al., PHARMACOKINETICS AND BIODISTRIBUTION OF IN-111-DTPA-G-CSF NONHUMAN-PRIMATES, Blood, 90(10), 1997, pp. 3548-3548
THE COST-EFFECTIVENESS OF UNRELATED DONOR BONE-MARROW TRANSPLANTATION(URD BMT) FOR CHRONIC MYELOGENOUS LEUKEMIA (CML)
Authors: LEE SJ ANASETTI C KUNTZ KM PATTEN J ANTIN JH WEEKS JC
Citation: Sj. Lee et al., THE COST-EFFECTIVENESS OF UNRELATED DONOR BONE-MARROW TRANSPLANTATION(URD BMT) FOR CHRONIC MYELOGENOUS LEUKEMIA (CML), Blood, 90(10), 1997, pp. 472-472
OUTCOME FOLLOWING T-CELL DEPLETED (TCD) VERSUS NON-T-CELL DEPLETED (NON-TCD) ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLO BMT) FOR CHRONIC MYELOGENOUS LEUKEMIA (CML) - IMPACT OF DONOR LYMPHOCYTE INFUSIONS (DLI)
Authors: SEHN LH ANTIN JH WELLER E ALYEA EP CANNING C RITZ J SOIFFER RJ
Citation: Lh. Sehn et al., OUTCOME FOLLOWING T-CELL DEPLETED (TCD) VERSUS NON-T-CELL DEPLETED (NON-TCD) ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLO BMT) FOR CHRONIC MYELOGENOUS LEUKEMIA (CML) - IMPACT OF DONOR LYMPHOCYTE INFUSIONS (DLI), Blood, 90(10), 1997, pp. 1006-1006
TREATMENT OF SEVER VENOOCCLUSIVE DISEASE (VOD) WITH DEFIBROTIDE (DF) - COMPASSIONATE USE RESULTS IN EFFICACY WITHOUT SIGNIFICANT TOXICITY IN A HIGH-RISK POPULATION
Authors: RICHARDSON PG ELIAS AD KRISHNAN A WHEELER C NATH R HOPPENSTEADT D WALLER EK ANTIN JH SOIFFER RJ VREDENBURGH J BEARMAN SI IACOBELLI M FAREED J GUINAN EC
Citation: Pg. Richardson et al., TREATMENT OF SEVER VENOOCCLUSIVE DISEASE (VOD) WITH DEFIBROTIDE (DF) - COMPASSIONATE USE RESULTS IN EFFICACY WITHOUT SIGNIFICANT TOXICITY IN A HIGH-RISK POPULATION, Blood, 90(10), 1997, pp. 1107-1107
Risultati: 1-25 | 26-50 | 51-60